317 related articles for article (PubMed ID: 19514091)
21. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
Tee MC; Pirozzi N; Brahmbhatt RD; Raman S; Franko J
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1941-1947. PubMed ID: 32466860
[TBL] [Abstract][Full Text] [Related]
22. Impact of different surgical procedures on survival outcomes of patients with adenocarcinoma of pancreatic neck.
Zheng Z; Tan C; Chen Y; Ping J; Wang M
PLoS One; 2019; 14(5):e0217427. PubMed ID: 31125386
[TBL] [Abstract][Full Text] [Related]
23. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
25. Readmission after pancreatectomy for pancreatic cancer in Medicare patients.
Reddy DM; Townsend CM; Kuo YF; Freeman JL; Goodwin JS; Riall TS
J Gastrointest Surg; 2009 Nov; 13(11):1963-74; discussion 1974-5. PubMed ID: 19760307
[TBL] [Abstract][Full Text] [Related]
26. Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients With Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race.
Hester CA; Kothari AN; Mason M; Maxwell J; Ikoma N; Kim MP; Tzeng CD; Lee JE; Katz MHG; Cao HST
Ann Surg; 2023 Feb; 277(2):321-328. PubMed ID: 34183508
[TBL] [Abstract][Full Text] [Related]
27. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
[TBL] [Abstract][Full Text] [Related]
28. The incidence and outcomes of pancreatectomy in patients with metastatic pancreatic adenocarcinoma.
McKenzie S; Mailey B; Artinyan A; Kim J; Ellenhorn JD
JOP; 2010 Jul; 11(4):341-7. PubMed ID: 20601808
[TBL] [Abstract][Full Text] [Related]
29. Persistent racial disparities in refusal of resection in non-small cell lung cancer patients at high-volume and Black-serving institutions.
Coaston TN; Sakowitz S; Chervu NL; Branche C; Shuch BM; Benharash P; Revels S
Surgery; 2023 Dec; 174(6):1428-1435. PubMed ID: 37821266
[TBL] [Abstract][Full Text] [Related]
30. Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals.
Olecki EJ; Perez Holguin RA; Mayhew MM; Wong WG; Vining CC; Peng JS; Shen C; Dixon MEB
J Surg Res; 2024 Feb; 294():160-168. PubMed ID: 37897875
[TBL] [Abstract][Full Text] [Related]
31. Racial disparities in esophageal cancer survival after surgery.
Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Bhora F; Flores RM
J Surg Oncol; 2016 May; 113(6):659-64. PubMed ID: 26865174
[TBL] [Abstract][Full Text] [Related]
32. Racial disparities in esophageal cancer treatment and outcomes.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; McGinn TG; Wisnivesky JP
Ann Surg Oncol; 2008 Mar; 15(3):881-8. PubMed ID: 17987341
[TBL] [Abstract][Full Text] [Related]
33. Persistence of racial disparities in early-stage lung cancer treatment.
Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
[TBL] [Abstract][Full Text] [Related]
34. Racial differences in brain cancer characteristics and survival: an analysis of SEER data.
Bytnar JA; Lin J; Shriver CD; Zhu K
Cancer Causes Control; 2019 Dec; 30(12):1283-1291. PubMed ID: 31641915
[TBL] [Abstract][Full Text] [Related]
35. Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis.
McDowell BD; Chapman CG; Smith BJ; Button AM; Chrischilles EA; Mezhir JJ
Ann Surg; 2015 Apr; 261(4):740-5. PubMed ID: 24979599
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System.
Khalaf N; Xu A; Nguyen Wenker T; Kramer JR; Liu Y; Singh H; El-Serag HB; Kanwal F
Pancreas; 2024 Jan; 53(1):e27-e33. PubMed ID: 37967826
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
38. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
39. Surgery for Localized Pancreatic Cancer: The Trend Is Not Improving.
Strohl MP; Raigani S; Ammori JB; Hardacre JM; Kim JA
Pancreas; 2016; 45(5):687-93. PubMed ID: 26491905
[TBL] [Abstract][Full Text] [Related]
40. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
Zell JA; Rhee JM; Ziogas A; Lipkin SM; Anton-Culver H
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):546-52. PubMed ID: 17372250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
